March 2015 FDA Recall Drug by Fusion Pharmaceuticals, Llc
D-0410-2015 - Microbial Contamination of a Non-Sterile Product

This Class II drug recall was voluntarily initiated by Fusion Pharmaceuticals, Llc on March 6, 2015 for the product Drug. The FDA reported the reason for recall as microbial contamination of a non-sterile product. The product was distributed in California and the recall is currently terminated.

Recall Number: D-0410-2015

Reason for Recall
Microbial Contamination of a Non-Sterile Product: Kit component is contaminated with Burkholderia multivorans.
Initiated
03-06-2015
Reported
03-18-2015
Quantity
9,439 Kits

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Fusion Pharmaceuticals, LLC
DICOPANOL (diphenhydramine hydrochloride in 5 mg/mL oral suspension kit) FusePaq, 150 mL Kits, Rx Only. Fusion Pharmaceuticals LLC., 768 Calle Plano, Camarillo, CA 93012. NDC: 43093-104-01.

Batch or Lot Expiration Information

Lot# Lot Numbers: PL713, PL714, PL715, PL716, PL717, PL718, PL719, PL720, PL721, PL722, PL735, PL736, PL737, PL738, PL739, PL740, PL741, PL742, PL743, PL744; Expiry: 7/20/2015.